Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Thu, 22.01.2026
HIAG Immobilien Holding AG
Ad hoc announcement pursuant to Art. 53 LR
Media information
Media information (PDF)
Basel, 22 January 2026 – HIAG Immobilien Holding AG currently expects its consolidated net profit for the 2025 financial year to be 50% to 55% higher than the previous year's figure (2024 financial year: CHF 75.2 million). The net result should therefore signific [ … ]
Thu, 22.01.2026
Carl Zeiss Meditec AG
Q1 FY 2025/26 earnings clearly below past year - FY 2025/26 guidance will likely not be achieved
Jena, January 22, 2026
In the first 3 months of fiscal year (FY) 2025/26 ending December 31, 2025, Carl Zeiss Meditec AG (ISIN: DE0005313704) recorded preliminary revenue of € 467 million (prior year: € 490 million). The revenue decline was ma [ … ]
Thu, 22.01.2026
HUBER+SUHNER AG
Ad hoc announcement pursuant to Art. 53 LR - 22.01.2026
Decline in net sales, organically at previous year's level – Industry segment sees strong growth – Communication segment posts significant increase in orders thanks to Data Center growth initiative – Transportation segment remains stable
Order intake and net sales in 2025 (unaudited)
[ … ]
Thu, 22.01.2026
Galenica AG
Press releaseAd hoc announcement pursuant to Art. 53 LR
Sales up by 5.5% to CHF 4,135.6 million
Broad-based growth – with all business areas contributing
Strong pharmacy business driven by prescription medicines and dietary supplements
Continuous growth in wholesale
New “Diagnostics” area contributes 1% to sales growth
EBIT1 guidance with 10- [ … ]
Wed, 21.01.2026
SNP Schneider-Neureither & Partner SE
Publication of Insider Information in accordance with Article 17 MAR
SNP SE: Revenue and EBIT in Fiscal Year 2025 Better Than Expected
Heidelberg, Germany, January 21, 2026 – Based on preliminary figures, SNP Schneider-Neureither & Partner SE (ISIN: DE0007203705) achieved revenues of approximately €296 million in 2025, thus exceeding the fore [ … ]
Tue, 20.01.2026
Aumann AG
Disclosure of inside information pursuant to Article 17 MARAumann will, according to first projections, significantly exceed its 2025 earnings forecast, despite slightly weaker sales of around €205 million, with an EBITDA margin of about 14%
Beelen, 20 January 2026
Aumann AG ("Aumann", ISIN: DE000A2DAM03) generated revenue of approximately €205 mil [ … ]
Tue, 20.01.2026
Ströer SE & Co. KGaA
Christian Schmalzl, Co-CEO of the general partner of Ströer SE & Co. KGaA, informed Supervisory Board Chairman Christoph Vilanek and his Co-CEO Udo Müller today that he will not be availabe for reappointment when his term expires in summer 2028 for personal reasons related to his life plans. The Chairman of the Supervisory Board and the general [ … ]
Tue, 20.01.2026
KOMAX Holding AG
Dierikon, 20 January 2026
Media releaseAd hoc announcement pursuant to Art. 53 LR
Preliminary information on 2025 financial year
Since 2024, the Komax Group has consistently adapted its cost structure to a changing market situation. This is positively reflected in the 2025 business result. Despite restructuring costs, negative currency effects, and [ … ]
Mon, 19.01.2026
clearvise AG
clearvise AG appoints Bernhard Gierke to the Executive Board – CEO Petra Leue-Bahns steps down as planned at the end of her term of office
Frankfurt, January 19, 2026 – The Supervisory Board of clearvise AG (WKN A1EWXA / ISIN DE000A1EWXA4), a renewable energy electricity producer, has appointed Bernhard Gierke as the new Chief Executive Officer (C [ … ]
Mon, 19.01.2026
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability
Baar, 19 January 2026 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful cl [ … ]
